The Cooper Companies, Inc. (NASDAQ:COO) Stake Raised by Neo Ivy Capital Management

Neo Ivy Capital Management boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 108.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 18,159 shares of the medical device company's stock after buying an additional 9,441 shares during the period. Neo Ivy Capital Management's holdings in Cooper Companies were worth $1,669,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of COO. Price T Rowe Associates Inc. MD grew its position in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after buying an additional 2,957,421 shares in the last quarter. Norges Bank acquired a new stake in shares of Cooper Companies during the fourth quarter worth approximately $217,906,000. FMR LLC grew its position in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after buying an additional 1,095,805 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Cooper Companies during the fourth quarter worth approximately $64,826,000. Finally, Victory Capital Management Inc. grew its position in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after buying an additional 574,899 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $1.76 during midday trading on Tuesday, reaching $80.59. 2,684,416 shares of the company traded hands, compared to its average volume of 1,498,312. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The stock has a 50-day moving average price of $80.23 and a 200 day moving average price of $88.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market cap of $16.12 billion, a price-to-earnings ratio of 41.33, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Robert W. Baird decreased their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a report on Wednesday, May 21st. Finally, Citigroup decreased their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.